209 related articles for article (PubMed ID: 15476149)
1. The wizards of odds: cost-effectiveness, Barrett's screening, and surveillance guidelines.
Perdue DG; Murray J; Wang KK
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):865-7. PubMed ID: 15476149
[No Abstract] [Full Text] [Related]
2. Screening and surveillance in Barrett's esophagus: a call to action.
Eisen GM; Lieberman D; Fennerty MB; Sonnenberg A
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):861-4. PubMed ID: 15476148
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
Gerson LB; Groeneveld PW; Triadafilopoulos G
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):868-79. PubMed ID: 15476150
[TBL] [Abstract][Full Text] [Related]
4. Screening and surveillance of Barrett's esophagus.
Regula J
Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961
[TBL] [Abstract][Full Text] [Related]
5. Are screening and surveillance for Barrett's oesophagus really worthwhile?
Sharma P; Sidorenko EI
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
[TBL] [Abstract][Full Text] [Related]
6. Summaries for patients. Cost-effectiveness of screening and surveillance for Barrett esophagus.
Ann Intern Med; 2003 Feb; 138(3):I-41. PubMed ID: 12558382
[No Abstract] [Full Text] [Related]
7. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
[TBL] [Abstract][Full Text] [Related]
8. Screening for Barrett's esophagus.
Zakko L; Lutzke L; Wang KK
Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
[TBL] [Abstract][Full Text] [Related]
9. Should we screen patients for Barrett's esophagus? No: the case against screening.
Knox MA
Am Fam Physician; 2011 May; 83(10):1148, 1150. PubMed ID: 21568247
[No Abstract] [Full Text] [Related]
10. Role of surveillance endoscopy, biopsy and biomarkers in early detection of Barrett's adenocarcinoma.
Ellis FH; Loda M
Dis Esophagus; 1997 Jul; 10(3):165-71. PubMed ID: 9280074
[No Abstract] [Full Text] [Related]
11. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.
Benaglia T; Sharples LD; Fitzgerald RC; Lyratzopoulos G
Gastroenterology; 2013 Jan; 144(1):62-73.e6. PubMed ID: 23041329
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance for Barrett's oesophagus: worthwhile?].
Kastelein F; Kuipers EJ
Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
[TBL] [Abstract][Full Text] [Related]
13. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
[TBL] [Abstract][Full Text] [Related]
14. How far to go? Screening and surveillance in Barrett's esophagus.
Lieberman DA; Sampliner RE
Am J Manag Care; 2001 Feb; 7(1 Suppl):S19-26. PubMed ID: 11225349
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
Kamboj AK; Katzka DA; Iyer PG
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
[TBL] [Abstract][Full Text] [Related]
16. Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.
Inadomi JM
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):51-63. PubMed ID: 25743456
[TBL] [Abstract][Full Text] [Related]
17. Screening strategies in gastroesophageal reflux disease: early identification of esophageal carcinoma.
Shaheen NJ; Provenzale D
Adv Intern Med; 2001; 47():137-57. PubMed ID: 11795073
[No Abstract] [Full Text] [Related]
18. Endoscopic surveillance of Barrett's esophagus: another viewpoint.
Richter JE
Am J Gastroenterol; 1993 May; 88(5):630-2. PubMed ID: 8480722
[No Abstract] [Full Text] [Related]
19. Defining a clinically significant adverse impact of diagnosing Barrett's esophagus.
Rubenstein JH; Inadomi JM
J Clin Gastroenterol; 2006 Feb; 40(2):109-15. PubMed ID: 16394870
[TBL] [Abstract][Full Text] [Related]
20. Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
Rubenstein JH; Inadomi JM; Brill JV; Eisen GM
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):312-8. PubMed ID: 17368230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]